Early In-Bed Cycle Ergometry in Mechanically Ventilated Patients Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • BACKGROUND: Critical illness requiring invasive mechanical ventilation can precipitate important functional disability, contributing to multidimensional morbidity following admission to an intensive care unit (ICU). Early in-bed cycle ergometry added to usual physiotherapy may mitigate ICU-acquired physical function impairment. METHODS: We randomly assigned 360 adult ICU patients undergoing invasive mechanical ventilation to receive 30 minutes of early in-bed Cycling + Usual physiotherapy (n=178) or Usual physiotherapy alone (n=182). The primary outcome was the Physical Function ICU Test-scored (PFIT-s) at 3 days after discharge from the ICU (the score ranges from 0 to 10, with higher scores indicating better function). RESULTS: Cycling began within a median (interquartile range) of 2 (1 to 3) days of starting mechanical ventilation; patients received 3 (2 to 5) cycling sessions for a mean (±standard deviation) of 27.2 ± 6.6 minutes. In both groups, patients started Usual physiotherapy within 2 (2 to 4) days of mechanical ventilation and received 4 (2 to 7) Usual physiotherapy sessions. The duration of Usual physiotherapy was 23.7 ± 15.1 minutes in the Cycling + Usual physiotherapy group and 29.1 ± 13.2 minutes in the Usual physiotherapy group. No serious adverse events occurred in either group. Among survivors, the PFIT-s at 3 days after discharge from the ICU was 7.7 ± 1.7 in the Cycling + Usual physiotherapy group and 7.5 ± 1.7 in the Usual physiotherapy group (absolute difference, 0.23 points; 95% confidence interval, -0.19 to 0.65; P=0.29). CONCLUSIONS: Among adults receiving mechanical ventilation in the ICU, adding early in-bed Cycling to usual physiotherapy did not improve physical function at 3 days after discharge from the ICU compared with Usual physiotherapy alone. Cycling did not cause any serious adverse events. (Funded by the Canadian Institutes of Health Research and others; ClinicalTrials.gov numbers, NCT03471247 [full randomized clinical trial] and NCT02377830 [CYCLE Vanguard 46-patient internal pilot].).

authors

  • Kho, Michelle
  • Berney, Susan
  • Pastva, Amy M
  • Kelly, Laurel
  • Reid, Julie C
  • Burns, Karen EA
  • Seely, Andrew J
  • D’Aragon, Frédérick
  • Rochwerg, Bram
  • Ball, Ian
  • Fox-Robichaud, Alison E
  • Karachi, Tim
  • Lamontagne, Francois
  • Archambault, Patrick M
  • Tsang, Jennifer L
  • Duan, Erick H
  • Muscedere, John
  • Verceles, Avelino C
  • Serri, Karim
  • English, Shane W
  • Reeve, Brenda K
  • Mehta, Sangeeta
  • Rudkowski, Jill C
  • Heels-Ansdell, Diane
  • O’Grady, Heather K
  • Strong, Geoff
  • Obrovac, Kristy
  • Ajami, Daana
  • Camposilvan, Laura
  • Tarride, Jean-Eric
  • Thabane, Lehana
  • Herridge, Margaret S
  • Cook, Deborah

publication date

  • June 25, 2024